Literature DB >> 20980614

Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain.

Jakob S Satz1, Adam P Ostendorf, Shangwei Hou, Amy Turner, Hajime Kusano, Jane C Lee, Rolf Turk, Huy Nguyen, Susan E Ross-Barta, Steve Westra, Toshinori Hoshi, Steven A Moore, Kevin P Campbell.   

Abstract

Cobblestone (type II) lissencephaly and mental retardation are characteristic features of a subset of congenital muscular dystrophies that include Walker-Warburg syndrome, muscle-eye-brain disease, and Fukuyama-type congenital muscular dystrophy. Although the majority of clinical cases are genetically undefined, several causative genes have been identified that encode known or putative glycosyltransferases in the biosynthetic pathway of dystroglycan. Here we test the effects of brain-specific deletion of dystroglycan, and show distinct functions for neuronal and glial dystroglycan. Deletion of dystroglycan in the whole brain produced glial/neuronal heterotopia resembling the cerebral cortex malformation in cobblestone lissencephaly. In wild-type mice, dystroglycan stabilizes the basement membrane of the glia limitans, thereby supporting the cortical infrastructure necessary for neuronal migration. This function depends on extracellular dystroglycan interactions, since the cerebral cortex developed normally in transgenic mice that lack the dystroglycan intracellular domain. Also, forebrain histogenesis was preserved in mice with neuron-specific deletion of dystroglycan, but hippocampal long-term potentiation was blunted, as is also the case in the Largemyd mouse, in which dystroglycan glycosylation is disrupted. Our findings provide genetic evidence that neuronal dystroglycan plays a role in synaptic plasticity and that glial dystroglycan is involved in forebrain development. Differences in dystroglycan glycosylation in distinct cell types of the CNS may contribute to the diversity of dystroglycan function in the CNS, as well as to the broad clinical spectrum of type II lissencephalies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980614      PMCID: PMC2979314          DOI: 10.1523/JNEUROSCI.3247-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  70 in total

1.  Cre recombinase expression in cerebellar Purkinje cells.

Authors:  J J Barski; K Dethleffsen; M Meyer
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

2.  hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo.

Authors:  L Zhuo; M Theis; I Alvarez-Maya; M Brenner; K Willecke; A Messing
Journal:  Genesis       Date:  2001-10       Impact factor: 2.487

Review 3.  Dystroglycan: from biosynthesis to pathogenesis of human disease.

Authors:  Rita Barresi; Kevin P Campbell
Journal:  J Cell Sci       Date:  2006-01-15       Impact factor: 5.285

4.  Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells.

Authors:  K J Langenbach; T A Rando
Journal:  Muscle Nerve       Date:  2002-11       Impact factor: 3.217

5.  Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor.

Authors:  S H Gee; F Montanaro; M H Lindenbaum; S Carbonetto
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

6.  Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1.

Authors:  A Yoshida; K Kobayashi; H Manya; K Taniguchi; H Kano; M Mizuno; T Inazu; H Mitsuhashi; S Takahashi; M Takeuchi; R Herrmann; V Straub; B Talim; T Voit; H Topaloglu; T Toda; T Endo
Journal:  Dev Cell       Date:  2001-11       Impact factor: 12.270

7.  Co-localization of fukutin and alpha-dystroglycan in the mouse central nervous system.

Authors:  Eiko Ohtsuka-Tsurumi; Yoshiaki Saito; Tomoko Yamamoto; Thomas Voit; Makio Kobayashi; Makiko Osawa
Journal:  Brain Res Dev Brain Res       Date:  2004-09-17

8.  LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.

Authors:  Rita Barresi; Daniel E Michele; Motoi Kanagawa; Hollie A Harper; Sherri A Dovico; Jakob S Satz; Steven A Moore; Wenli Zhang; Harry Schachter; Jan P Dumanski; Ronald D Cohn; Ichizo Nishino; Kevin P Campbell
Journal:  Nat Med       Date:  2004-06-06       Impact factor: 53.440

9.  Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin alpha5 chain.

Authors:  J H Miner; J Cunningham; J R Sanes
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

10.  Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier.

Authors:  Simona Occhi; Desirée Zambroni; Ubaldo Del Carro; Stefano Amadio; Erich E Sirkowski; Steven S Scherer; Kevin P Campbell; Steven A Moore; Zulin-L Chen; Sidney Strickland; Antonio Di Muzio; Antonino Uncini; Lawrence Wrabetz; M Laura Feltri
Journal:  J Neurosci       Date:  2005-10-12       Impact factor: 6.167

View more
  61 in total

Review 1.  Molecular and functional heterogeneity of GABAergic synapses.

Authors:  Jean-Marc Fritschy; Patrizia Panzanelli; Shiva K Tyagarajan
Journal:  Cell Mol Life Sci       Date:  2012-08       Impact factor: 9.261

2.  RPTPζ/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1.

Authors:  C A Dwyer; E Baker; H Hu; R T Matthews
Journal:  Neuroscience       Date:  2012-06-19       Impact factor: 3.590

3.  C. elegans dystroglycan coordinates responsiveness of follower axons to dorsal/ventral and anterior/posterior guidance cues.

Authors:  Robert P Johnson; James M Kramer
Journal:  Dev Neurobiol       Date:  2012-07-27       Impact factor: 3.964

4.  Expression of dystrophins and the dystrophin-associated-protein complex by pituicytes in culture.

Authors:  Abdelkader Bougrid; Thomas Claudepierre; Serge Picaud; Ghazi Ayad; Dominique Mornet; Latifa Dorbani-Mamine; Alvaro Rendon; Halima Darbeida
Journal:  Neurochem Res       Date:  2011-04-12       Impact factor: 3.996

Review 5.  Glia unglued: how signals from the extracellular matrix regulate the development of myelinating glia.

Authors:  Holly Colognato; Iva D Tzvetanova
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

6.  LARGE, an intellectual disability-associated protein, regulates AMPA-type glutamate receptor trafficking and memory.

Authors:  Bo Am Seo; Taesup Cho; Daniel Z Lee; Joong-Jae Lee; Boyoung Lee; Seong-Wook Kim; Hee-Sup Shin; Myoung-Goo Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

7.  Laminin α1 is essential for mouse cerebellar development.

Authors:  Naoki Ichikawa-Tomikawa; Junko Ogawa; Vanessa Douet; Zhuo Xu; Yuji Kamikubo; Takashi Sakurai; Shinichi Kohsaka; Hideki Chiba; Nobutaka Hattori; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Matrix Biol       Date:  2011-09-29       Impact factor: 11.583

Review 8.  Glycan susceptibility factors in autism spectrum disorders.

Authors:  Chrissa A Dwyer; Jeffrey D Esko
Journal:  Mol Aspects Med       Date:  2016-07-11

9.  Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy.

Authors:  Tobias Geis; Klaus Marquard; Tanja Rödl; Christof Reihle; Sophie Schirmer; Thekla von Kalle; Antje Bornemann; Ute Hehr; Markus Blankenburg
Journal:  Neurogenetics       Date:  2013-09-20       Impact factor: 2.660

10.  Chronic stress impairs the aquaporin-4-mediated glymphatic transport through glucocorticoid signaling.

Authors:  Fang Wei; Jian Song; Cui Zhang; Jun Lin; Rong Xue; Li-Dong Shan; Shan Gong; Guo-Xing Zhang; Zheng-Hong Qin; Guang-Yin Xu; Lin-Hui Wang
Journal:  Psychopharmacology (Berl)       Date:  2019-01-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.